Ingredient in common cough medicine may aid diabetes treatment
the ONA take:
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes, according to a study published in Nature Medicine.
Researchers examined the effects of dextromethorphan, an active ingredient in cough suppressants, in order to build on prior research which showed that it had potential impact on receptor cells in the pancreas. Initially they hypothesized that the compound would actually worsen insulin production.
Instead, the team found that the ingredient caused the receptor cells to boost insulin production in the pancreas.
They tested the effect with a single-dose trial in 20 male patients with diabetes and found that the men “showed enhanced serum insulin concentrations and glucose tolerance.”
Findings, however, are still preliminary, and the researchers advise against diabetics self-medicating with cough medicine. Future testing was encouraged by the team.
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|